Cytosorbents (CTSO) Return on Invested Capital (2016 - 2025)
Cytosorbents (CTSO) posted Return on Invested Capital of 0.01% for Q4 2025, up 73.59% on a QoQ basis from 0.03% in Q4 2024, and up 2.0% year-over-year from 0.01% in Q4 2024.
Cytosorbents (CTSO) Return on Invested Capital (2016 - 2025) Analysis & Trends
Cytosorbents' Return on Invested Capital history runs 9 years deep, the most recent figure standing at 0.01% for Q4 2025.
- Quarterly Return on Invested Capital rose 2.0% year-over-year to 0.01% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.01% (up 2.0% YoY) and the FY2019 annual result came in at 0.15%, down 9.0% from the prior year.
- Return on Invested Capital was 0.01% for Q4 2025 at Cytosorbents, up from 0.03% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.01% in Q1 2021 and bottomed at 0.14% in Q4 2023.
- A 4-year average of 0.04% and a median of 0.03% in 2024 frame the typical range for Return on Invested Capital.
- Annual changes were most pronounced in 2021 — Return on Invested Capital changed 0 bps — and 2024, when it rose 11 bps.
- Cytosorbents' Return on Invested Capital stood at 0.01% in 2021, then tumbled by 1472 bps to 0.14% in 2023, then surged by 76 bps to 0.03% in 2024, then jumped by 74 bps to 0.01% in 2025.
- Business Quant data shows CTSO's Return on Invested Capital at 0.01% in Q4 2025, 0.03% in Q4 2024, and 0.04% in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.01% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.01% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.01% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.00% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.00% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.00% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.03% |
| Sep 30, 2024 | -0.04% |
| Mar 31, 2024 | -0.06% |
| Dec 31, 2023 | -0.14% |
| Jun 30, 2021 | -0.01% |
| Mar 31, 2021 | -0.01% |
| Dec 31, 2020 | 0.00% |
| Sep 30, 2020 | -0.01% |
| Jun 30, 2020 | -0.01% |
| Mar 31, 2020 | -0.02% |
| Dec 31, 2019 | -0.03% |
| Sep 30, 2019 | -0.04% |
| Jun 30, 2019 | -0.06% |
| Mar 31, 2019 | -0.11% |
| Dec 31, 2018 | -0.06% |
| Sep 30, 2018 | -0.02% |
| Jun 30, 2018 | -0.02% |
| Mar 31, 2018 | -0.01% |
| Dec 31, 2017 | -0.01% |